SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes.

Joshua Sterling Wells Chao Wang Kevin Dolgin Reem Kayyali

Published in: Patient preference and adherence (2023)

Higher levels of MA, as determined by SPUR, were significantly associated with a lower risk of general admissions and early readmissions among patients living with Type 2 Diabetes.

Keyphrases

patient reported
end stage renal disease
ejection fraction
newly diagnosed
emergency department
chronic kidney disease
prognostic factors